Gecko is a privately owned life science company developing innovative polymer solutions for Tissue Reconstruction.
Gecko has developed a fully industrialised platform allowing the swift development of proprietary medical devices around its polymer families.
Gecko Biomedical was founded in 2013 & is based in Paris, Ile-de-France, France.
Gecko's platform is focused on cardiovascular, bone, nerve, ophthalmic and urology applications. A first product has been CE marked in 2017 for application in vascular reconstruction.
Gecko’s vision is to create an ecosystem around its versatile technology platform that will drive innovation in Tissue Reconstruction.
Gecko is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement among others.